News

Last year, the company acquired Canadian and US licensing rights to the drug Xenazine, by purchasing Prestwick Pharmaceuticals. It was the company’s first foray into the CNS disorder

Henry Nordhoff, who had served as its CEO since 1994, is now non-executive chairman following his re-election to the board at the company’s annual meeting of stockholders last

In addition to implementing cost cutting measures, particularly in the area of executive compensation and other operating areas, the company is also contemplating the separation of its OTC

The parent company took the decision as MediCult A/S – a leader in Assisted Reproductive Technologies – did not reach the required share threshold within the set timeframe

According to pharma industry experts, outsourcing research and manufacturing of pharma products helps global pharma majors to reduce costs by almost 30-50%, due to the availability of talent

Preclinical study was conducted at the Roswell Park Cancer Institute in Buffalo, New York, wherein Aptocine was used to treat primary tumors and examine prevention of metastases in

The projects will promote understanding of health issues such as diabetes, pain, severe asthma and psychiatric disorders, while enhancing the safety and efficiency of new medicines. The awards

Paul Vibert, general manager of Baxter China said: “the investment represents the company’s commitment to China and that he expects that the company can achieve double-digit sales growth

Manufacturing a vaccine from the present strain of the virus entails some risk, as the virus is capable of mutating into a form that can turn the vaccine